Effect of misoprostol (PGE1) on glucose metabolism in type-2-diabetic and control subjects

N. A. Lee, M. Matsuda, P. Bressler, T. Pratipanawatr, L. Glass, L. J. Mandarino, Ralph A Defronzo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In vitro and in vivo studies have demonstrated that prostaglandins of the E series enhance muscle glucose uptake. We examined the effect of acute misoprostol (PGE1) administration on whole body insulin-mediated glucose disposal, as well as the major intracellular pathways of glucose metabolism in type 2 diabetic (n=10) and non-diabetic (n=4) subjects. Each subject received two 240-min euglycaemic insulin (40 mU/m2/min) clamp studies with tritiated glucose and indirect calorimetry. During one of the insulin clamp studies, 200 μg of misoprostol was ingested at 90 and 150 min after the start of the insulin infusion. Insulin-mediated total body glucose disposal, glycolysis, glycogenesis and glucose oxidation were similar during the insulin clamp studies performed without and with misoprostol in both the diabetic and non-diabetic groups. These results demonstrate that the acute administration of misoprostol does not enhance insulin-mediated glucose disposal in either type-2-diabetic or non-diabetic subjects.

Original languageEnglish (US)
Pages (from-to)195-200
Number of pages6
JournalDiabetes, Obesity and Metabolism
Volume4
Issue number3
DOIs
StatePublished - 2002

Fingerprint

Misoprostol
Alprostadil
Insulin
Glucose
Indirect Calorimetry
Glycolysis
Prostaglandins E
Muscles

Keywords

  • Glucose metabolism
  • Insulin resistance
  • Misoprostol (PGE1)
  • Prostglandin E1
  • Type 2 diabetes mellitus

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Effect of misoprostol (PGE1) on glucose metabolism in type-2-diabetic and control subjects. / Lee, N. A.; Matsuda, M.; Bressler, P.; Pratipanawatr, T.; Glass, L.; Mandarino, L. J.; Defronzo, Ralph A.

In: Diabetes, Obesity and Metabolism, Vol. 4, No. 3, 2002, p. 195-200.

Research output: Contribution to journalArticle

Lee, N. A. ; Matsuda, M. ; Bressler, P. ; Pratipanawatr, T. ; Glass, L. ; Mandarino, L. J. ; Defronzo, Ralph A. / Effect of misoprostol (PGE1) on glucose metabolism in type-2-diabetic and control subjects. In: Diabetes, Obesity and Metabolism. 2002 ; Vol. 4, No. 3. pp. 195-200.
@article{b73720e4c57245fbb53586d4bd7ffc8a,
title = "Effect of misoprostol (PGE1) on glucose metabolism in type-2-diabetic and control subjects",
abstract = "In vitro and in vivo studies have demonstrated that prostaglandins of the E series enhance muscle glucose uptake. We examined the effect of acute misoprostol (PGE1) administration on whole body insulin-mediated glucose disposal, as well as the major intracellular pathways of glucose metabolism in type 2 diabetic (n=10) and non-diabetic (n=4) subjects. Each subject received two 240-min euglycaemic insulin (40 mU/m2/min) clamp studies with tritiated glucose and indirect calorimetry. During one of the insulin clamp studies, 200 μg of misoprostol was ingested at 90 and 150 min after the start of the insulin infusion. Insulin-mediated total body glucose disposal, glycolysis, glycogenesis and glucose oxidation were similar during the insulin clamp studies performed without and with misoprostol in both the diabetic and non-diabetic groups. These results demonstrate that the acute administration of misoprostol does not enhance insulin-mediated glucose disposal in either type-2-diabetic or non-diabetic subjects.",
keywords = "Glucose metabolism, Insulin resistance, Misoprostol (PGE1), Prostglandin E1, Type 2 diabetes mellitus",
author = "Lee, {N. A.} and M. Matsuda and P. Bressler and T. Pratipanawatr and L. Glass and Mandarino, {L. J.} and Defronzo, {Ralph A}",
year = "2002",
doi = "10.1046/j.1463-1326.2002.00203.x",
language = "English (US)",
volume = "4",
pages = "195--200",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Effect of misoprostol (PGE1) on glucose metabolism in type-2-diabetic and control subjects

AU - Lee, N. A.

AU - Matsuda, M.

AU - Bressler, P.

AU - Pratipanawatr, T.

AU - Glass, L.

AU - Mandarino, L. J.

AU - Defronzo, Ralph A

PY - 2002

Y1 - 2002

N2 - In vitro and in vivo studies have demonstrated that prostaglandins of the E series enhance muscle glucose uptake. We examined the effect of acute misoprostol (PGE1) administration on whole body insulin-mediated glucose disposal, as well as the major intracellular pathways of glucose metabolism in type 2 diabetic (n=10) and non-diabetic (n=4) subjects. Each subject received two 240-min euglycaemic insulin (40 mU/m2/min) clamp studies with tritiated glucose and indirect calorimetry. During one of the insulin clamp studies, 200 μg of misoprostol was ingested at 90 and 150 min after the start of the insulin infusion. Insulin-mediated total body glucose disposal, glycolysis, glycogenesis and glucose oxidation were similar during the insulin clamp studies performed without and with misoprostol in both the diabetic and non-diabetic groups. These results demonstrate that the acute administration of misoprostol does not enhance insulin-mediated glucose disposal in either type-2-diabetic or non-diabetic subjects.

AB - In vitro and in vivo studies have demonstrated that prostaglandins of the E series enhance muscle glucose uptake. We examined the effect of acute misoprostol (PGE1) administration on whole body insulin-mediated glucose disposal, as well as the major intracellular pathways of glucose metabolism in type 2 diabetic (n=10) and non-diabetic (n=4) subjects. Each subject received two 240-min euglycaemic insulin (40 mU/m2/min) clamp studies with tritiated glucose and indirect calorimetry. During one of the insulin clamp studies, 200 μg of misoprostol was ingested at 90 and 150 min after the start of the insulin infusion. Insulin-mediated total body glucose disposal, glycolysis, glycogenesis and glucose oxidation were similar during the insulin clamp studies performed without and with misoprostol in both the diabetic and non-diabetic groups. These results demonstrate that the acute administration of misoprostol does not enhance insulin-mediated glucose disposal in either type-2-diabetic or non-diabetic subjects.

KW - Glucose metabolism

KW - Insulin resistance

KW - Misoprostol (PGE1)

KW - Prostglandin E1

KW - Type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=0036265228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036265228&partnerID=8YFLogxK

U2 - 10.1046/j.1463-1326.2002.00203.x

DO - 10.1046/j.1463-1326.2002.00203.x

M3 - Article

VL - 4

SP - 195

EP - 200

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

SN - 1462-8902

IS - 3

ER -